| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 10 | 2023 | 413 | 1.230 |
Why?
|
| Intellectual Disability | 17 | 2023 | 1032 | 1.090 |
Why?
|
| De Lange Syndrome | 4 | 2023 | 43 | 0.640 |
Why?
|
| Abnormalities, Multiple | 13 | 2021 | 998 | 0.610 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 192 | 0.560 |
Why?
|
| Developmental Disabilities | 9 | 2023 | 674 | 0.550 |
Why?
|
| Facies | 5 | 2021 | 149 | 0.510 |
Why?
|
| Phenotype | 21 | 2023 | 6295 | 0.510 |
Why?
|
| Microcephaly | 7 | 2023 | 325 | 0.480 |
Why?
|
| Movement Disorders | 3 | 2023 | 232 | 0.450 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2012 | 38 | 0.430 |
Why?
|
| Genetic Association Studies | 6 | 2023 | 1084 | 0.410 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 142 | 0.400 |
Why?
|
| Mutation, Missense | 8 | 2023 | 1152 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 16 | 5 | 2018 | 254 | 0.390 |
Why?
|
| Craniofacial Abnormalities | 5 | 2021 | 239 | 0.340 |
Why?
|
| Mutation | 13 | 2023 | 15179 | 0.330 |
Why?
|
| DNA Copy Number Variations | 6 | 2018 | 1516 | 0.310 |
Why?
|
| Chromosome Deletion | 7 | 2014 | 1005 | 0.310 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 434 | 0.310 |
Why?
|
| Transcription Factors | 9 | 2023 | 5270 | 0.310 |
Why?
|
| Medulloblastoma | 1 | 2012 | 540 | 0.300 |
Why?
|
| Acrocephalosyndactylia | 1 | 2006 | 17 | 0.290 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2018 | 92 | 0.280 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 96 | 0.270 |
Why?
|
| Myotonic Dystrophy | 1 | 2007 | 151 | 0.270 |
Why?
|
| Haploinsufficiency | 4 | 2023 | 294 | 0.260 |
Why?
|
| Myotonin-Protein Kinase | 2 | 2020 | 36 | 0.260 |
Why?
|
| Homozygote | 1 | 2007 | 717 | 0.260 |
Why?
|
| Child | 27 | 2023 | 29154 | 0.250 |
Why?
|
| Child, Preschool | 21 | 2021 | 16273 | 0.250 |
Why?
|
| Genetic Variation | 3 | 2021 | 2086 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 5539 | 0.230 |
Why?
|
| Sequence Deletion | 3 | 2016 | 875 | 0.230 |
Why?
|
| Nuclear Proteins | 5 | 2023 | 3343 | 0.230 |
Why?
|
| Mosaicism | 2 | 2022 | 272 | 0.220 |
Why?
|
| Glypicans | 2 | 2013 | 51 | 0.220 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 15 | 0.220 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 69 | 0.220 |
Why?
|
| Gene Duplication | 5 | 2015 | 421 | 0.220 |
Why?
|
| Glutamate-tRNA Ligase | 1 | 2021 | 1 | 0.200 |
Why?
|
| Infant | 17 | 2021 | 13310 | 0.200 |
Why?
|
| Exons | 2 | 2017 | 1328 | 0.200 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2020 | 14 | 0.200 |
Why?
|
| Adolescent | 22 | 2021 | 31252 | 0.190 |
Why?
|
| Infant, Newborn | 14 | 2021 | 8223 | 0.190 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 63 | 0.190 |
Why?
|
| Cell Cycle Proteins | 3 | 2023 | 2045 | 0.190 |
Why?
|
| Chromosome Aberrations | 4 | 2022 | 1960 | 0.190 |
Why?
|
| Cataract | 2 | 2004 | 218 | 0.180 |
Why?
|
| Exome | 4 | 2020 | 1239 | 0.180 |
Why?
|
| Mental Disorders | 3 | 2015 | 862 | 0.180 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 108 | 0.180 |
Why?
|
| Epilepsy | 3 | 2021 | 883 | 0.180 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 39 | 0.180 |
Why?
|
| Male | 39 | 2023 | 123000 | 0.180 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 28 | 0.180 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2019 | 23 | 0.180 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 411 | 0.170 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2019 | 38 | 0.170 |
Why?
|
| Cockayne Syndrome | 2 | 2004 | 24 | 0.170 |
Why?
|
| Gene Rearrangement | 3 | 2019 | 783 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2016 | 691 | 0.170 |
Why?
|
| Heterozygote | 3 | 2020 | 1020 | 0.170 |
Why?
|
| INDEL Mutation | 1 | 2019 | 112 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 534 | 0.160 |
Why?
|
| Humans | 54 | 2023 | 261506 | 0.160 |
Why?
|
| Muscle Hypotonia | 1 | 2019 | 180 | 0.160 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 26 | 0.160 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 126 | 0.160 |
Why?
|
| Nephrosis | 1 | 2017 | 5 | 0.160 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 644 | 0.160 |
Why?
|
| Language Development Disorders | 2 | 2017 | 167 | 0.150 |
Why?
|
| Holoprosencephaly | 2 | 2009 | 21 | 0.150 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 63 | 0.150 |
Why?
|
| Histone Deacetylases | 2 | 2023 | 365 | 0.150 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 589 | 0.150 |
Why?
|
| Urogenital Abnormalities | 2 | 2021 | 174 | 0.150 |
Why?
|
| Genome, Human | 3 | 2017 | 1869 | 0.150 |
Why?
|
| Actins | 1 | 2019 | 608 | 0.140 |
Why?
|
| Genotype | 7 | 2021 | 4109 | 0.140 |
Why?
|
| Female | 37 | 2023 | 141928 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2019 | 362 | 0.140 |
Why?
|
| Arginine | 1 | 2019 | 500 | 0.140 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 16 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 220 | 0.130 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 473 | 0.130 |
Why?
|
| Cohort Studies | 9 | 2021 | 9244 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2018 | 519 | 0.130 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 28 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 126 | 0.130 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 84 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 395 | 0.130 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 194 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 208 | 0.130 |
Why?
|
| Otx Transcription Factors | 1 | 2014 | 22 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 365 | 0.130 |
Why?
|
| Cranial Fontanelles | 1 | 2014 | 4 | 0.120 |
Why?
|
| Hypertelorism | 1 | 2014 | 14 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 174 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 170 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2014 | 172 | 0.120 |
Why?
|
| Saccule and Utricle | 1 | 2013 | 10 | 0.120 |
Why?
|
| Gigantism | 1 | 2013 | 15 | 0.120 |
Why?
|
| Genes, X-Linked | 1 | 2014 | 66 | 0.120 |
Why?
|
| Frameshift Mutation | 3 | 2020 | 220 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 442 | 0.110 |
Why?
|
| Syndrome | 5 | 2023 | 1351 | 0.110 |
Why?
|
| Pedigree | 4 | 2018 | 1890 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 69 | 0.110 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 118 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 291 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2015 | 291 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2015 | 829 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2021 | 4233 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 2022 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 363 | 0.100 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 1245 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 854 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2023 | 1664 | 0.100 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 139 | 0.100 |
Why?
|
| Tetrasomy | 1 | 2010 | 1 | 0.100 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2010 | 11 | 0.100 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2011 | 83 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 108 | 0.090 |
Why?
|
| Heart Defects, Congenital | 3 | 2021 | 1697 | 0.090 |
Why?
|
| Chromosome Duplication | 1 | 2010 | 157 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2010 | 181 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2010 | 121 | 0.090 |
Why?
|
| Gene Deletion | 4 | 2017 | 1442 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 234 | 0.090 |
Why?
|
| Young Adult | 9 | 2021 | 21445 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 231 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 1265 | 0.090 |
Why?
|
| Chromosome Disorders | 2 | 2011 | 417 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 402 | 0.080 |
Why?
|
| Genes, Dominant | 2 | 2007 | 331 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 613 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2017 | 844 | 0.080 |
Why?
|
| Scrotum | 2 | 2021 | 57 | 0.080 |
Why?
|
| Prostate | 1 | 2013 | 1088 | 0.080 |
Why?
|
| Adult | 13 | 2021 | 77950 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 169 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 1489 | 0.080 |
Why?
|
| Intracranial Thrombosis | 1 | 2007 | 17 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 327 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2015 | 6150 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 641 | 0.070 |
Why?
|
| Cystine | 1 | 2006 | 34 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2022 | 2232 | 0.070 |
Why?
|
| Karyotyping | 2 | 2022 | 1022 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2017 | 338 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 388 | 0.060 |
Why?
|
| Alleles | 3 | 2021 | 2437 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 212 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2010 | 786 | 0.060 |
Why?
|
| Zebrafish | 2 | 2017 | 463 | 0.060 |
Why?
|
| Urinary Bladder | 2 | 2019 | 575 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 6089 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 829 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 2283 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2017 | 1258 | 0.060 |
Why?
|
| Hyperphagia | 1 | 2023 | 45 | 0.060 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2023 | 44 | 0.060 |
Why?
|
| Cleft Palate | 1 | 2005 | 128 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2003 | 150 | 0.060 |
Why?
|
| Oxytocin | 1 | 2023 | 62 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 2508 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2018 | 778 | 0.050 |
Why?
|
| Autistic Disorder | 2 | 2020 | 319 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 4821 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 315 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2021 | 8 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2017 | 1732 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2021 | 21 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2021 | 32 | 0.050 |
Why?
|
| Patella | 1 | 2021 | 44 | 0.050 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Dysostoses | 1 | 2000 | 2 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 317 | 0.050 |
Why?
|
| Acidosis, Lactic | 1 | 2021 | 33 | 0.050 |
Why?
|
| Animals | 8 | 2021 | 59536 | 0.050 |
Why?
|
| Joint Instability | 1 | 2021 | 88 | 0.050 |
Why?
|
| Scapula | 1 | 2000 | 37 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 577 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 75 | 0.050 |
Why?
|
| Shoulder | 1 | 2000 | 62 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 709 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7222 | 0.050 |
Why?
|
| Chromosome Breakage | 2 | 2011 | 226 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 335 | 0.050 |
Why?
|
| Cerebellar Ataxia | 1 | 2020 | 72 | 0.050 |
Why?
|
| Mice | 6 | 2021 | 34495 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2020 | 388 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 2019 | 42 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 132 | 0.040 |
Why?
|
| Cornea | 1 | 2004 | 638 | 0.040 |
Why?
|
| Megalencephaly | 1 | 2019 | 56 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 380 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 481 | 0.040 |
Why?
|
| Pelvis | 1 | 2000 | 362 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1144 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 82 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2018 | 69 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 88 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 195 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 153 | 0.040 |
Why?
|
| Trisomy | 1 | 1998 | 231 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 7702 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 332 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2017 | 77 | 0.040 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 57 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 73 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 1471 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 287 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 170 | 0.040 |
Why?
|
| Glaucoma | 1 | 1997 | 92 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 154 | 0.040 |
Why?
|
| Siblings | 1 | 2018 | 285 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 276 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 163 | 0.040 |
Why?
|
| Face | 1 | 2019 | 273 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2018 | 512 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 2291 | 0.040 |
Why?
|
| Podocytes | 1 | 2017 | 120 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 4549 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 267 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1546 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 370 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 1179 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 120 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 670 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 204 | 0.030 |
Why?
|
| Pregnancy | 4 | 2015 | 7573 | 0.030 |
Why?
|
| Cataract Extraction | 1 | 1997 | 184 | 0.030 |
Why?
|
| Point Mutation | 1 | 2018 | 769 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 842 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 81 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2015 | 70 | 0.030 |
Why?
|
| Genitalia | 1 | 2014 | 46 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 323 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 834 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 1282 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1559 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 2013 | 36 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 2013 | 88 | 0.030 |
Why?
|
| Penis | 1 | 2013 | 123 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 128 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 2146 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 2738 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2013 | 98 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1070 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 1143 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1648 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 2074 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 47 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 989 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 111 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2015 | 1234 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 7551 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 3101 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 43 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 2466 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 425 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 1872 | 0.020 |
Why?
|
| Protein S | 1 | 2007 | 11 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2007 | 26 | 0.020 |
Why?
|
| Factor V | 1 | 2007 | 20 | 0.020 |
Why?
|
| Prothrombin | 1 | 2007 | 36 | 0.020 |
Why?
|
| Protein C | 1 | 2007 | 32 | 0.020 |
Why?
|
| Antithrombin III | 1 | 2007 | 28 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 73 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 542 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 102 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 73 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 2819 | 0.020 |
Why?
|
| Family | 1 | 2011 | 736 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2010 | 324 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2007 | 113 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 126 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 274 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 325 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 14889 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 495 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 369 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 3203 | 0.020 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2004 | 36 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 4917 | 0.020 |
Why?
|
| Microphthalmos | 1 | 2004 | 57 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2003 | 43 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 747 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 385 | 0.010 |
Why?
|
| Xenopus | 1 | 2003 | 219 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 377 | 0.010 |
Why?
|
| Placenta | 1 | 2007 | 516 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2005 | 218 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 2483 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 7591 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 611 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 869 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 575 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 17523 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 3260 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 70117 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2003 | 270 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 4758 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 826 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2000 | 36 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2007 | 1555 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 173 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 2000 | 68 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 200 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 1113 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2000 | 318 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1998 | 76 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 2944 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 237 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3639 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 575 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 1904 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 1998 | 643 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 4744 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 37905 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2003 | 4654 | 0.000 |
Why?
|